Some patients receiving adefovir dipivoxil( Hepsera) at the approved dose of10 mg daily for the treatment of chronic hepatitis B virus( HBV) infection have a suboptimal virological response characterized by a slow and moderate decrease in HBV replication.

• 有些接受阿德福韦核准每天10毫克药量治疗慢性乙肝感染的患者常出现缓慢，中度减低病毒复制的不佳抗病毒效应。